Jobs / United States / Novartis Pharmaceuticals Corporation
Medical Oncology Head
Novartis Pharmaceuticals Corporation · 🇺🇸 Toranomon (NPKK Head Office)
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles7 certified filings for “Director, Resource Optimization Commercial” (Medical and Health Services Managers) in NJ: $183k–$223k, median $223k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary -Lead global medical affairs team for compound(s) of responsibility and represent GMA at GPT or lead region or country TA medical team and represent TA in global teams. Drive global medical plan & disease are strategy, action plan & execution of medical activities or co-own Medical Affairs plan/co-lead the medical franchise strategy for region or country roles. Provide medical leadership in cross-functional teams to support integrated disease area plans or drive execution of country Medical Affairs activities. Job Description The Medical TA Head defines and executes the country-specific medical strategy for the assigned Therapeutic Area, ensuring aligned and impactful delivery of scientific engagement, medical education, evidence generation, and cross‑functional support. The role serves as the country’s scientific leader for the TA, shaping strategy, guiding external customer and field engagement, and ensuring high scientific standards across all medical activities throughout the product lifecycle. Medical TA Strategy • Adapt international medical plans into a country tailored Medical TA strategy supporting prelaunch, launch and lifecycle management. • Build a strategic orientation and tactical plans across external insights, medical education, and publication planning. • Set and oversee the local data generation strategy (RWE, HEOR inputs, evidence generation, Phase IV/IIIb) including publication plans. • Provide scientific and clinical expertise to inform trial design, feasibility, integrated evidence strategies, and local clinical programs. • Serve as the disease area expert for internal stakeholders (Marketing, Market Access, Regulatory, Commercial, Digital). • Guarantee ERC/compliance in all medical activities and materials. Medical Engagement • Lead and guide all peer-to-peer scientific exchange with HCPs and Medical Experts (MEs) to ensure credible, unbiased, scientific dialogue. • Oversee MSL strategic direction, ensuring coherent field engagement plans aligned to TA strategy. • Ensure systematic external insight gathering and translate insights into strategic recommendations. • Support internal teams with medical knowledge , clinical data interpretation, and training. • Ensure medical teams maintain highest standards in evidence based, ethical engagement . Medical Education & Scientific Communication • Design and execute the medical education strategy , including scientific events, symposia, hospital meetings, and congress activities. • Localize and produce high quality scientific communication materials (presentations, publications, external education tools). • Partner with Medical Customer Excellence and other internal functions on external scientific event planning , vendor management, congress measurement and reporting. • Lead or support publication planning for the country TA. • Provide scientific inputs to EE Capability Building to design/localize capability programs/curricula for medical teams and for TA teams and partner for the delivery of those. Medical Partnerships • Build and maintain strong partnerships with Medical Experts, scientific societies, and academic institutions to support collaboration and scientific leadership in the TA. • Partner cross-functionally with Commercial TA Heads, Value & Access, Regulatory, Execution Excellence and global/international/regional medical teams. • Represent the company as the credible scientific ambassador in the TA, contributing to a positive reputation with key stakeholders and institutions. • Strengthen the medical ecosystem by shaping joint value creation initiatives , evidence based collaborations, and multistakeholder partnerships. Leadership & Culture • Foster an engaged, high-performance culture wit